Clinical trial Recruiting at 1 site Observational

Ultrafast ultrasound imaging for congenital heart disease in children

Official title: Ultrafast Ultrasound Imaging: Application in Pediatric Cardiology: Cardiac Ultrafast

Run by University Hospital, Bordeaux · NCT07255144 · Data updated 2026-11-12

This project will try ultrafast ultrasound to measure heart muscle stiffness and blood flow in children with congenital heart disease.

More Congenital Heart Disease (CHD) trials

Quick facts

Study typeObservational
SexAll
Enrollment300 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Pessac, France)
StatusRecruiting
StartedMarch 11, 2025
Main results expectedMarch 11, 2028
Study endsMarch 11, 2028
Registry record updatedNovember 28, 2025
Trial IDNCT07255144 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children of any age with congenital heart disease seen at the CHD department, plus otherwise-healthy children coming for check-ups or with small ASD/PFO, who have French social security coverage and parental or legal guardian consent.

Probably not a fit

Children with arrhythmias, segmental kinetic disorders, implanted pacemakers/defibrillators, or those who cannot tolerate ultrasound gel are excluded and would not benefit from this imaging approach in the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will use an open-platform Verasonics ultrafast ultrasound system to capture very high-frame-rate cardiac images and derive measures of myocardial stiffness and perfusion in pediatric CHD patients. The observational protocol enrolls CHD patients of any age seen at the cardiology department and includes a comparison group of otherwise-healthy children or those with small ASD/PFO. Key exclusions are arrhythmia, segmental wall motion disorders, implanted cardiac devices, anechoic imaging, and allergy to ultrasound gel. Collected UFUS metrics will be compared to standard echocardiographic findings to look for signals related to impaired diastolic filling.

Why it matters

Potential benefit: If successful, UFUS could provide quicker, noninvasive measures of heart stiffness and perfusion to better detect diastolic problems and help guide treatment in children with CHD.

How similar studies have gone: Ultrafast ultrasound has shown promising results for myocardial mechanics and perfusion in adult and preclinical studies, but its use specifically in pediatric CHD is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Every patient of CHD department of any age or any sex:

  * Patients with CHD
  * General population patients in good general health as evidenced by medical history coming to our department for a check-up OR diagnosed with small Atrial Septal Defect or small Patent Foramen Ovale
* Social security affiliation
* Parental or legal guardian's non-opposition

Exclusion Criteria:

* Arrhythmia
* Segmental kinetic disorder.
* Pacemaker or multisite stimulation, defibrillator,
* Anechoic
* Allergy to echocardiography gel.

Where it's running

  • Hôpital Cardiologique Haut Lévêque
    Pessac, France, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.